EA200001101A1 - НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ - Google Patents

НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ

Info

Publication number
EA200001101A1
EA200001101A1 EA200001101A EA200001101A EA200001101A1 EA 200001101 A1 EA200001101 A1 EA 200001101A1 EA 200001101 A EA200001101 A EA 200001101A EA 200001101 A EA200001101 A EA 200001101A EA 200001101 A1 EA200001101 A1 EA 200001101A1
Authority
EA
Eurasian Patent Office
Prior art keywords
group
optionally substituted
aryl
formula
hydrogen atom
Prior art date
Application number
EA200001101A
Other languages
English (en)
Other versions
EA003996B1 (ru
Inventor
Анри-Филипп Юссон
Сильвиан Жиоржи-Рено
Кристоф Тратра
Ганем Атасси
Алан Пьер
Пьер Ренар
Брюно Пфейффер
Original Assignee
Адир Э Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Адир Э Компани filed Critical Адир Э Компани
Publication of EA200001101A1 publication Critical patent/EA200001101A1/ru
Publication of EA003996B1 publication Critical patent/EA003996B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Предложены соединения формулы (I)гдепредставляет собой одинарную или двойную связь,Rпредставляет собой атом водорода или гидроксильную или алкоксигруппу,каждый из Rи R, которые одинаковы или различны, представляет собой атом водорода или атом галогена, или алкильную, алкоксигруппу, гидроксильную группу, полигалогеналкильную группу, нитрогруппу, необязательно замещенную аминогруппу или группу формулыгде m представляет собой целое число, причем 1 ≤ m ≤ 4, или вместе с несущими их атомами углерода образуют ароматическую или неароматическую, моно- или бициклическую группу, содержащую в кольце от 5 до 12 членов, необязательно содержащую 1 или 2 гетероатома, выбираемых их O, S или N,Rпредставляет собой атом водорода или арильную группу, гетероарильную группу, циклоалкильную группу, необязательно замещенную алкильную группу или группу формулы CORгде заместитель Rпредставляет собой арильную группу, необязательно замещенную алкильную группу, необязательно замещенную аминогруппу или группу OR, где заместитель Rпредставляет собой арильную группу или необязательно замещенную алкильную группу,X представляет собой атом кислорода или атом серы или группу -CH- или -CH-CH-,Ar представляет собой арил, гетероарил или арилалкильную группу,их оптические изомеры, их гидраты и сольваты, а также их аддитивные соли с фармацевтически приемлемой кислотой. Также предложены лекарственные средства.
EA200001101A 1999-11-24 2000-11-23 НОВЫЕ ДИГИДРОФУРО[3, 4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ EA003996B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9914771A FR2801310B1 (fr) 1999-11-24 1999-11-24 NOUVEAUX DERIVES DE DIHYDROFURO-[3,4-b]QUINOLEIN-1-ONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Publications (2)

Publication Number Publication Date
EA200001101A1 true EA200001101A1 (ru) 2001-06-25
EA003996B1 EA003996B1 (ru) 2003-12-25

Family

ID=9552476

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200001101A EA003996B1 (ru) 1999-11-24 2000-11-23 НОВЫЕ ДИГИДРОФУРО[3, 4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ

Country Status (22)

Country Link
US (1) US6548515B1 (ru)
EP (1) EP1103554B9 (ru)
JP (1) JP3566649B2 (ru)
KR (1) KR100433705B1 (ru)
CN (1) CN1157394C (ru)
AT (1) ATE234305T1 (ru)
AU (1) AU781300B2 (ru)
BR (1) BR0005557A (ru)
CA (1) CA2326710C (ru)
DE (1) DE60001622T2 (ru)
DK (1) DK1103554T5 (ru)
EA (1) EA003996B1 (ru)
ES (1) ES2194692T3 (ru)
FR (1) FR2801310B1 (ru)
HK (1) HK1036983A1 (ru)
HU (1) HUP0004704A3 (ru)
MX (1) MXPA00011240A (ru)
NO (1) NO20005922L (ru)
NZ (1) NZ508390A (ru)
PL (1) PL344100A1 (ru)
SI (1) SI1103554T1 (ru)
ZA (1) ZA200006912B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2825092B1 (fr) * 2001-05-23 2005-01-14 Servier Lab Nouveau derives trycicliques de dihydro-quinoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2825091B1 (fr) * 2001-05-23 2003-07-04 Servier Lab Nouveaux derives tricycliques de dihydro-quinnoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN100376582C (zh) * 2006-04-26 2008-03-26 浙江大学 一种六氢呋喃[3,2-c]喹啉衍生物的制备方法
CN101092420B (zh) * 2006-06-23 2010-08-25 北京师范大学 (1z,4e,5z)-6-n-异丙基-6-氮杂-2-氧代-3-氧杂-4-甲氧基-双环[3.1.0]己烷及其制备方法和用途
CN101092419B (zh) * 2006-06-23 2010-05-12 北京师范大学 (1z,4z,5z)-6-n-烷基-6-氮杂-2-氧代-3-氧杂-4-甲氧基-双环[3.1.0]己烷及其制备方法和用途
WO2012076942A1 (en) * 2010-12-06 2012-06-14 Council Of Scientific & Industrial Research 4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
AU2015205995A1 (en) 2014-01-15 2016-07-28 Centre National De La Recherche Scientifique (Cnrs) Water soluble 4-azapodophyllotoxin analogs
US11098052B2 (en) * 2016-03-02 2021-08-24 Arizona Board Of Regents On Behalf Of Arizona State University 4-azapodophylotoxins compounds
CN110256457A (zh) * 2019-06-21 2019-09-20 江苏师范大学 一种4,7-二氢噻吩并[3,4-b]吡啶-5(1H)-酮化合物的合成方法
CN110684033B (zh) * 2019-09-06 2021-05-11 广西师范大学 四氢呋喃二喹啉化合物及其合成方法和应用
US11731980B1 (en) 2023-03-22 2023-08-22 King Faisal University Furo[3,4-b]quinolone compounds as antibacterial agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2310746A1 (de) * 1973-03-03 1974-09-12 Bayer Ag Verfahren zur herstellung von neuen 1,4-dihydrochinolinen sowie ihre verwendung als arzneimittel
IT1228293B (it) * 1989-02-06 1991-06-07 Angeli Inst Spa Benzoderivati di composti eterociclici contenenti azoto.
EP0585913B1 (en) * 1992-09-04 1997-12-29 Takeda Chemical Industries, Ltd. Condensed heterocyclic compounds, their production and use
ATE188377T1 (de) * 1993-06-29 2000-01-15 Takeda Chemical Industries Ltd Chinoline oder chinazolin-derivate und deren verwendung zur herstellung eines medikaments für die behandlung von osteoporose
US6376516B1 (en) * 1997-08-19 2002-04-23 Emory University Noscapine and noscapine derivatives, useful as anticancer agents

Also Published As

Publication number Publication date
EA003996B1 (ru) 2003-12-25
EP1103554B9 (fr) 2003-12-17
CN1157394C (zh) 2004-07-14
EP1103554A1 (fr) 2001-05-30
KR100433705B1 (ko) 2004-05-31
HUP0004704A3 (en) 2003-11-28
JP3566649B2 (ja) 2004-09-15
ES2194692T3 (es) 2003-12-01
NO20005922L (no) 2001-05-25
DE60001622T2 (de) 2004-02-05
SI1103554T1 (en) 2003-08-31
CN1302804A (zh) 2001-07-11
DK1103554T3 (da) 2003-07-14
KR20010051924A (ko) 2001-06-25
NZ508390A (en) 2001-03-30
BR0005557A (pt) 2001-07-17
ATE234305T1 (de) 2003-03-15
HK1036983A1 (en) 2002-01-25
DK1103554T5 (da) 2004-04-26
HU0004704D0 (ru) 2001-02-28
DE60001622D1 (de) 2003-04-17
ZA200006912B (en) 2001-06-05
AU781300B2 (en) 2005-05-12
FR2801310A1 (fr) 2001-05-25
EP1103554B1 (fr) 2003-03-12
PL344100A1 (en) 2001-06-04
AU7182500A (en) 2001-05-31
FR2801310B1 (fr) 2004-04-16
MXPA00011240A (es) 2002-05-23
US6548515B1 (en) 2003-04-15
JP2001151756A (ja) 2001-06-05
HUP0004704A2 (hu) 2001-11-28
CA2326710C (fr) 2006-06-27
CA2326710A1 (fr) 2001-05-24
NO20005922D0 (no) 2000-11-23

Similar Documents

Publication Publication Date Title
ZA200505273B (en) Novel compound
MXPA05007496A (es) Tienopirimidindionas y su uso en la modulacion de enfermedades autoinmunes.
NO20054224L (no) Nye 2-pyridinkarboksamidderivater
ATE338754T1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
MXPA04000677A (es) Tienopirimidindionas y su uso en modulacion de enfermedades autoinmunes.
EA200001101A1 (ru) НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
TNSN07357A1 (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
EA200501148A1 (ru) Пиридилоксиметильные и бензизоксазольные азабициклические производные
ZA868630B (en) New 3-oxadiazole and 3-carboxylic acid beta-carboline derivatives,their production and their use as drugs
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
UA50722C2 (ru) Translated By PlajНИТРОБЕНЗАМИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
EA200301171A1 (ru) Новые соединения трициклических дигидрохинолинов, способ их получения и фармацевтические композиции, содержащие их
EA200101170A1 (ru) Галоидпроизводные 9-деоксо-9а-аза-9а-гомоэритромицина а
EA200500716A1 (ru) Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат
EA200000527A3 (ru) Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их
ES2174077T3 (es) Derivados de hidroxilamina antiisquemicos y composiciones farmaceuticas.
SE0400440D0 (sv) Novel Cinnamic Amides
EA200301172A1 (ru) Новые соединения трициклических дигидрохинолинов, способ их получения и фармацевтические композиции, содержащие их
EA200200379A2 (ru) Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции
HUP0100751A2 (hu) Új aril-vagy heteroaril-kinolinilfoszfonsav-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények
HRP20050376A2 (en) Novel process for the preparation of imidazolyl compounds
ES2026452T3 (es) Un procedimiento para preparar 6h-isoxazolo/ 3,4-d/pirazolo/3,4-b/piridinas.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU